Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer

被引：0
|
作者：
Hattori, Masashi
Fujii, Tsutomu
Suenaga, Masaya
Yamada, Suguru
Kanda, Mitsuro
Iwata, Naoki
Kobayashi, Daisuke
Tanaka, Chie
Nakayama, Goro
Sugimoto, Hiroyuki
Koike, Masahiko
Nomoto, Shuji
Fujiwara, Michitaka
Kodera, Yasuhiro
机构：
[1] Nagoya Univ, Dept Gastroenterol Surg Surg 2, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[2] Nagoya Univ, Dept Surg Gastroenterol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.302
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
302
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Chemoradiotherapy With S-1 in Patients With Borderline Resectable Pancreatic Cancer with Involvement of the Major Artery
    Suenaga, M.
    Fujii, T.
    Yamada, S.
    Okumura, N.
    Kobayashi, D.
    Tanaka, C.
    Nakayama, G.
    Sugimoto, H.
    Koike, M.
    Nomoto, S.
    Fujiwara, M.
    Takeda, S.
    Nakao, A.
    Kodera, Y.
    PANCREAS, 2012, 41 (08) : 1405 - 1405
  • [2] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [3] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [4] Efficacy of Neoadjuvant Chemotherapy Using Gemcitabine and S-1 for Resectable and Borderline Resectable Pancreatic Cancer
    Aoki, T.
    Mori, S.
    Sakuraoka, Y.
    Suzuki, T.
    Nishi, Y.
    Arakawa, T.
    Shimizu, T.
    Tago, K.
    Park, K. H.
    Harada, N.
    Shiraki, T.
    Iso, Y.
    Kubota, K.
    PANCREAS, 2019, 48 (10) : 1404 - 1404
  • [5] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [6] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [7] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [8] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [9] Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer
    Murakami, T.
    Mori, R.
    Matsuyama, R.
    Homma, Y.
    Nakazawa, M.
    Tanaka, Y.
    Miyake, K.
    Sawada, Y.
    Oota, Y.
    Hiroshima, Y.
    Kumamoto, T.
    Ueda, M.
    Takeda, K.
    Ichikawa, Y.
    Tanaka, K.
    Endo, I.
    PANCREAS, 2014, 43 (08) : 1394 - 1394
  • [10] Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer
    Cho, In Rae
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Seong, Jinsil
    Hwang, Ho Kyoung
    Kang, Chang Moo
    Lee, Woo Jung
    Park, Jeong Youp
    PANCREATOLOGY, 2013, 13 (05) : 539 - 543
12345